已收录 273085 条政策
 政策提纲
  • 暂无提纲
STUDIES ON TETRAHYDROISOQUINOLINES (THI) (II) PHARMACOLOGICAL ACTION ON CARDIOVASCULAR SYSTEM
[摘要] References(12)Cited-By(14)In the preceding paper, it was reported that 1-(3', 4', 5'-trimethoxybenzyl)-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline (III) was the most potent bronchodilator of all the tetrahydroisoquinoline derivatives tested. Its bronchodilating activities in vitro and in vivo were about 10 times and 5 times stronger respectively than those of isoproterenol (1). In view of the general correlation between the bronchodilating and cardiovascular actions exhibited by adrenergic β-stimulants, it is interesting to study the effects of this compound on the cardiovascular system. In addition to III, we also tested two other tetrahydroisoquinoline derivatives, 1-benzyl-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline (I) and 1-(3', 4'-ethylenedioxybenzyl)-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline (II), for their effects on the cardiovascular system of variuos experimental animals in comparison with the actions of isoproterenol on the same system. Of the three compounds, compound III was pharmacologically the most active. Compound I having the basic structure in the chemical sense belonged to the least active group. Compound II, in which both 3'- and 4'-hydroxy groups of tetrahydroisoquinoline are masked through formation of the ethylenedioxy linkage, had an intermediate pharmacological potency.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文